{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:59:04Z","timestamp":1792735144970,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["PROJECT 22582"],"award-info":[{"award-number":["PROJECT 22582"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["anr.fr\/Projet-ANR-22-CE14-0073"],"award-info":[{"award-number":["anr.fr\/Projet-ANR-22-CE14-0073"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005041","name":"Universit\u00e9 Catholique de Louvain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101534","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:04:26Z","timestamp":1752613466000},"page":"101534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["AAV-shDUX4 provides short-term benefits but limited long-term efficacy in a DUX4 mouse model of FSHD"],"prefix":"10.1016","volume":"33","author":[{"given":"S.","family":"Sohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Corbex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hourde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mariot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dumonceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101534_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41582-022-00762-2","article-title":"Facioscapulohumeral muscular dystrophy: the road to targeted therapies","volume":"19","author":"Tihaya","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtm.2025.101534_bib2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/humu.22593","article-title":"Genetic and Epigenetic Characteristics of FSHD-Associated 4q and 10q D4Z4 that are Distinct from Non-4q\/10q D4Z4 Homologs","volume":"35","author":"Zeng","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.omtm.2025.101534_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jmedgenet-2015-103436","article-title":"Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2","volume":"53","author":"Calandra","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001181","article-title":"Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene","volume":"6","author":"Snider","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160022","article-title":"Influence of Repressive Histone and DNA Methylation upon D4Z4 Transcription in Non-Myogenic Cells","volume":"11","author":"Das","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101534_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/hmg\/ddt409","article-title":"DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles","volume":"23","author":"Ferreboeuf","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib7","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1093\/hmg\/ddt272","article-title":"Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to Facio-Scapulo-Humeral Dystrophy","volume":"22","author":"Broucqsault","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10030073","article-title":"DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation","volume":"10","author":"Sidlauskaite","year":"2020","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.omtm.2025.101534_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.freeradbiomed.2016.08.007","article-title":"DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients","volume":"99","author":"Dmitriev","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.omtm.2025.101534_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.freeradbiomed.2012.06.041","article-title":"Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction","volume":"53","author":"Turki","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.omtm.2025.101534_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04996","article-title":"A feedback loop between nonsense-mediated decay and the retrogene DUX4 in facioscapulohumeral muscular dystrophy","volume":"4","author":"Feng","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.omtm.2025.101534_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112642","article-title":"Compromised nonsense-mediated RNA decay results in truncated RNA-binding protein production upon DUX4 expression","volume":"42","author":"Campbell","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2025.101534_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35150-8","article-title":"Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression","volume":"8","author":"Bosnakovski","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101534_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 Activates Germline Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral Dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omtm.2025.101534_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00730-1","article-title":"Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model","volume":"8","author":"Bosnakovski","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2025.101534_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/hmg\/ddaa031","article-title":"Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsies","volume":"29","author":"Wong","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib17","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/jcsm.12813","article-title":"RIPK3-mediated cell death is involved in DUX4-mediated toxicity in facioscapulohumeral dystrophy","volume":"12","author":"Mariot","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.omtm.2025.101534_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2007.04.002","article-title":"The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein","volume":"17","author":"Kowaljow","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2025.101534_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/hmg\/ddt314","article-title":"Wnt\/beta-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells","volume":"22","author":"Block","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092886","article-title":"Therapeutic Strategies Targeting DUX4 in FSHD","volume":"9","author":"Le Gall","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.omtm.2025.101534_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2022.937879","article-title":"Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy","volume":"4","author":"Mariot","year":"2022","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.omtm.2025.101534_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.omtn.2021.09.010","article-title":"Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy","volume":"26","author":"Bouwman","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2025.101534_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071623","article-title":"Long-Term Systemic Treatment of a Mouse Model Displaying Chronic FSHD-like Pathology with Antisense Therapeutics That Inhibit DUX4 Expression","volume":"10","author":"Lu-Nguyen","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtm.2025.101534_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/hum.2021.251","article-title":"Improving Molecular and Histopathology in Diaphragm Muscle of the Double Transgenic ACTA1-MCM\/FLExDUX4 Mouse Model of FSHD with Systemic Antisense Therapy","volume":"33","author":"Lu-Nguyen","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101534_bib25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/hmg\/ddab136","article-title":"Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model","volume":"30","author":"Lu-Nguyen","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092339","article-title":"A Systemically Administered Unconjugated Antisense Oligonucleotide Targeting DUX4 Improves Muscular Injury and Motor Function in FSHD Model Mice","volume":"11","author":"Kakimoto","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtm.2025.101534_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw7781","article-title":"A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression, and cell death","volume":"5","author":"Bosnakovski","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101534_bib28","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101534_bib29","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1093\/hmg\/ddu129","article-title":"Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases","volume":"23","author":"Ferreboeuf","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ana.24446","article-title":"Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy","volume":"78","author":"Mariot","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2025.101534_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192657","article-title":"A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy","volume":"13","author":"Jones","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101534_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s13395-020-00227-4","article-title":"Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity","volume":"10","author":"Jones","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2025.101534_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111377","article-title":"Molecular, Histological, and Functional Changes in Acta1-MCM;FLExDUX4\/+ Mice","volume":"25","author":"Sohn","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101534_bib34","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049016","article-title":"Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models","volume":"14","author":"Nunes","year":"2021","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2025.101534_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119503","article-title":"Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments","volume":"24","author":"Duranti","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101534_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25169065","article-title":"Oligonucleotide Therapies for Facioscapulohumeral Muscular Dystrophy: Current Preclinical Landscape","volume":"25","author":"Beck","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101534_bib37","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013695","article-title":"Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7","volume":"13","author":"Banerji","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2025.101534_bib38","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1038\/mt.2012.181","article-title":"Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping","volume":"20","author":"Vulin","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101534_bib39","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/hmg\/ddw201","article-title":"Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles","volume":"25","author":"Peccate","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib40","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/mt.2013.121","article-title":"AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy","volume":"21","author":"Le Hir","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101534_bib41","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/hmg\/ddaa164","article-title":"Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity","volume":"29","author":"Banerji","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mus.24621","article-title":"Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies","volume":"52","author":"Statland","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2025.101534_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s13395-024-00341-7","article-title":"Comparative in vivo characterization of newly discovered myotropic adeno-associated vectors","volume":"14","author":"Ji","year":"2024","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.omtm.2025.101534_bib44","unstructured":"Statland J, H.A., Zhu Y, Day J, Johnson N, Laverty C, Quan D, Quinn C, Subromony S, Tawil R, Arellano H, et al. Interim Results from FORTITUDE, a Randomized Phase 1\/2 Trial Evaluating AOC 1020 in Adults with FSHD. 2025. https:\/\/www.aviditybiosciences.com\/wp-content\/uploads\/2024\/10\/Final-NMSG-2024-FORTITUDE-Poster-16SEP24.pdf."},{"key":"10.1016\/j.omtm.2025.101534_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-04817-8","article-title":"Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers","volume":"12","author":"van den Heuvel","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101534_bib46","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1093\/hmg\/ddv315","article-title":"Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways","volume":"24","author":"Rickard","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101534_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12551-013-0135-x","article-title":"The excitation-contraction coupling mechanism in skeletal muscle","volume":"6","author":"Calderon","year":"2014","journal-title":"Biophys. Rev"},{"key":"10.1016\/j.omtm.2025.101534_bib48","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1113\/jphysiol.2010.190934","article-title":"Changes in the force-velocity relationship of fatigued muscle: implications for power production and possible causes","volume":"588","author":"Jones","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.omtm.2025.101534_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.846284","article-title":"Molecular Events of the Crossbridge Cycle Reflected in the Force-Velocity Relationship of Activated Muscle","volume":"13","author":"Seow","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtm.2025.101534_bib50","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mus.26841","article-title":"One-hour universal protocol for mouse genotyping","volume":"61","author":"Joubert","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2025.101534_bib51","first-page":"136","article-title":"The heat of shortening and the dynamic constants of muscle","volume":"126","author":"Hill","year":"1938","journal-title":"Proc. Royal Soc. B"}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:55:18Z","timestamp":1778867718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001299"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101534","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-shDUX4 provides short-term benefits but limited long-term efficacy in a DUX4 mouse model of FSHD","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101534"}}